These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38034017)

  • 61. Koumine inhibits RANKL-induced ubiquitination and NF-κB activation to prevent ovariectomy and aging-induced bone loss.
    You J; Xu D; Zhang C; Chen Y; Huang S; Bian H; Lv J; Chen D; Su L; Yin H; Li Y; Wang Y
    J Cell Biochem; 2024 Jan; 125(1):100-114. PubMed ID: 38031891
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
    Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
    Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cholesterol sulfate inhibits osteoclast differentiation and survival by regulating the AMPK-Sirt1-NF-κB pathway.
    Park JH; Lee J; Lee GR; Kwon M; Lee HI; Kim N; Kim HJ; Lee MO; Jeong W
    J Cell Physiol; 2023 Sep; 238(9):2063-2075. PubMed ID: 37334825
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Farrerol suppresses osteoclast differentiation and postmenopausal osteoporosis by inhibiting the nuclear factor kappa B signaling pathway.
    Lu W; Qi G; Yang X; Li D; Chen W; Zeng Q; Jiang Z
    J Pharmacol Sci; 2024 Feb; 154(2):113-126. PubMed ID: 38246725
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Staphylococcus Aureus Induces Osteoclastogenesis via the NF-κB Signaling Pathway.
    Ren LR; Wang ZH; Wang H; He XQ; Song MG; Xu YQ
    Med Sci Monit; 2017 Sep; 23():4579-4590. PubMed ID: 28942456
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice.
    Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J
    Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways.
    Chen G; Xu Q; Dai M; Liu X
    Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Salicortin inhibits osteoclast differentiation and bone resorption by down-regulating JNK and NF-κB/NFATc1 signaling pathways.
    Nie S; Xu J; Zhang C; Xu C; Liu M; Yu D
    Biochem Biophys Res Commun; 2016 Jan; 470(1):61-67. PubMed ID: 26740180
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anti-Osteoporotic Effects of
    Lim HJ; Park EJ; Won YS; Bak SG; Cheong SH; Lee SW; Lee S; Lee SJ; Rho MC
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833909
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative study of holothurin A and echinoside A on inhibiting the high bone turnover
    Yue H; Tian Y; Li Y; Bai X; Wang X; Wang Y; Li Z; Xue C; Wang J
    Food Funct; 2022 Apr; 13(8):4748-4756. PubMed ID: 35389397
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Garcinone C attenuates RANKL-induced osteoclast differentiation and oxidative stress by activating Nrf2/HO-1 and inhibiting the NF-kB signaling pathway.
    Ji H; Pan Q; Cao R; Li Y; Yang Y; Chen S; Gu Y; Qian D; Guo Y; Wang L; Wang Z; Xiao L
    Heliyon; 2024 Feb; 10(3):e25601. PubMed ID: 38333852
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Madecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesis.
    Wang Q; Yao L; Xu K; Jin H; Chen K; Wang Z; Liu Q; Cao Z; Kenny J; Liu Y; Tickner J; Xu H; Xu J
    J Cell Mol Med; 2019 Jan; 23(1):380-394. PubMed ID: 30338925
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways.
    Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y
    Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Specnuezhenide suppresses diabetes-induced bone loss by inhibiting RANKL-induced osteoclastogenesis.
    Ye X; Jiang J; Yang J; Yan W; Jiang L; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Aug; 54(8):1080-1089. PubMed ID: 35929595
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss.
    Han SY; Kim YK
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946658
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway.
    Chawalitpong S; Chokchaisiri R; Suksamrarn A; Katayama S; Mitani T; Nakamura S; Athamneh AA; Ritprajak P; Leelahavanichkul A; Aeimlapa R; Charoenphandhu N; Palaga T
    Sci Rep; 2018 Apr; 8(1):5625. PubMed ID: 29618833
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiotrophin Like Cytokine Factor 1 (CLCF1) alleviates bone loss in osteoporosis mouse models by suppressing osteoclast differentiation through activating interferon signaling and repressing the nuclear factor-κB signaling pathway.
    Yokota S; Matsumae G; Shimizu T; Hasegawa T; Ebata T; Takahashi D; Heguo C; Tian Y; Alhasan H; Takahata M; Kadoya K; Terkawi MA; Iwasaki N
    Bone; 2021 Dec; 153():116140. PubMed ID: 34364014
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid.
    Tan EM; Li L; Indran IR; Chew N; Yong EL
    J Bone Miner Res; 2017 Apr; 32(4):846-860. PubMed ID: 27813153
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Crocin inhibits RANKL-induced osteoclast formation and bone resorption by suppressing NF-κB signaling pathway activation.
    Fu L; Pan F; Jiao Y
    Immunobiology; 2017 Apr; 222(4):597-603. PubMed ID: 27871781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.